Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis
2016
Abstract Most of
systemic therapieshave not been systematically investigated in moderate to severe childhood plaque
psoriasis. Treatment preferences for moderate to severe
psoriasisin childhood are unknown. the objectives of this study were to investigate the systemic treatment patterns of moderate to severe
psoriasisin children and adolescents aged ≤ 18 years in Italy. Additional secondary outcomes were duration of treatment and reasons for discontinuation. to define differences in treatment patterns, we performed a chart review of all consecutive patients treated with systemic drugs during an index period of five years. Consecutive sampling of all patients with
psoriasis, aged ≤ 18 years, who had been treated with at least one systemic drug over a 5-year period, was made. the records of 58 consecutive patients, 27 males, 31 females. with moderate to severe
psoriasistreated with at least one
systemic therapywere reviewed. The median age (standard deviation) at the start of the first systemic treatment was 11.7 years (± 3.7). The most preferred first line systemic treatment was cyclosporine, which was administered as first systemic treatment in 53.4% of patients, followed by
acitretinin 22.4% of patients,
etanerceptand PUVA respectively in 8.6%, methotrexate in 6.8%. 48.2% of patients received a second systemic treatment due to inefficacy or side effects of the first line therapy during the index period. Because of the small sample, and voluntary contribution,
selection biasmay have occurred. a considerable variation in the management of the first line
systemic therapyin children with moderate to severe
psoriasiswas observed. Cyclosporine was most commonly preferred as a first-line treatment. The availability of new therapeutic agents could change the scenario of treatment patterns in childhood
psoriasis.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
8
Citations
NaN
KQI